Women with BRCA1,2 mutations are predisposed to breast/ovarian cancer syndrome and carry a lifetime risk of 60–80% for breast cancer and 40–50% ovarian cancer respectively [107]. Here, BRCA1 is linked to ovarian carcinoma.